Guerbet LLC

Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors, disposables, digital solutions and services at the 2018 annual meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.

Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM Watson Health in medical imaging, at the 2018 annual meeting of the Radiological Society of North America (RSNA), Nov. 25-30 in Chicago.

Guerbet announced it has signed an exclusive joint development agreement with IBM Watson Health to develop an artificial intelligence (AI) software solution to support liver cancer diagnostics. The AI software will focus on utilizing computed tomography (CT) and magnetic resonance imaging (MRI), and care.

The continuing search for advantages to improve workflow has radiology departments constantly searching for new solutions. While some, such as advanced operating systems and computer-aided diagnostics, can require a significant investment in terms of equipment expense or additional training, there is also a simple solution that can help healthcare professionals save steps in the administration of safe and effective care without added complication: prefilled contrast syringes.

Guerbet announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical Therapeutics , which specializes in the development of microcatheters used in interventional radiology.